Skip to playerSkip to main content
  • 1 week ago
Ozempic serves as a treatment for regulating blood sugar levels in individuals diagnosed with type 2 diabetes and may aid in weight management; however, it is associated with various significant health hazards. A review published in June 2026 highlights potential adverse effects such as pancreatitis, gallbladder conditions, diabetic retinopathy, renal issues, and thyroid neoplasms. The FDA has released a boxed warning regarding the possible risk of thyroid cancer, referencing tumors found in animal studies. Individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 are advised against using Ozempic. It is crucial for patients to consult with their healthcare professionals about these risks.
Disclosure:This video contains stock footage and content created or enhanced using Ai-assisted tools ai-generated

Category

🗞
News
Transcript
00:00Ozempic can help manage diabetes and support weight loss, but doctors warn about several
00:04serious potential side effects. One concern is pancreatitis, or inflammation of the pancreas.
00:10Symptoms can include severe abdominal pain, nausea, vomiting, and fever. Ozempic may also
00:16increase the risk of gallbladder problems. Warning signs include upper right abdominal pain,
00:21fever, and jaundice. Another concern is diabetic retinopathy, which can affect vision, blurred
00:27vision, floaters, or sudden vision loss need urgent attention. Kidney problems may also occur,
00:33especially with severe vomiting or dehydration. The FDA also warns about a potential thyroid cancer
00:39risk. That warning is based on thyroid tumors found in rodent studies. It remains unclear whether this
00:46risk occurs in humans. People with certain thyroid cancer histories should avoid Ozempic. Talk with
00:51your healthcare provider about the risks before taking it. Disclosure, this video contains stock
00:56footage and content created or enhanced using AI assisted tools AI generated.
Comments

Recommended